Vol. 4 No. 2 (2023): JOURNAL OF CARDIORESPIRATORY RESEARCH
Subject of the article
KORONAVIRUS KASALLIGI O‘TKAZGAN BEMORLARDA ARTERIAL GIPERTENZIYANING KECHISH XUSUSIYATLARI (73-76)
Authors
Nurillaeva N.M., Yarmukhammedova D.Z
Institution
Ташкентская медицинская академия
Abstract
Пандемия COVID-19 вызвала беспрецедентную заболеваемость, смертность и глобальные потрясения в обществе. Учитывая высокую распространенность артериальной гипертензии (АГ), а также факт заинтересованности компонентов ренин-ангиотензин-альдостероновой системы (РААС) в отношении проникновения вируса в организм, в условиях пандемии коронавирусной инфекции необходимо дальнейшее изучение особенностей течения АГ у перенесших COVID-19. Исследование проведена на базе кардиологического отделения многопрофильной клиники Ташкентской медицинской академии. Нестабильное АД статистически значимо (p=0,031) чаще было зафиксировано у пациентов, с АГ, перенесших ковид-19, по сравнению с группой пациентов с АГ без ковид-19 (35,0% против 25,0%).
Key words
артериальная гипертония, клинические особенности, коронавирусная инфекция.
Literature
Li W., Moore M., Vasilieva N., et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus // Nature. 2003; 426: 450-454. DOI: https://doi.org/10.1038/nature02145. Yfc`S^ ]ScW[acXdb[cSeac`nh[dd^XWaUS`[\¬ ɮ ɹɮɖɮɮɹ№2 | 2023 76 2. Lan J., Ge J., Yu J., et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor // Nature. 2020; 581: 215-220. DOI: https://doi.org/10.1038/s41586-020-2180-5. 3. Walls A. C., et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein // Cell. 2020; 181: 281-292. DOI: https://doi.org/10.1016/j.cell.2020.02.058. 4. Li F., Li W., Farzan M., Harrison S. C. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor // Science. 2005; 309: 1864-1868. DOI: https://doi.org/10.1126/science.1116480. 5. Wang Q., Zhang Y., Wu L., Niu S., et al. Structural and functional basis of SARS-CoV-2 entry by using human ACE2 // Cell. 2020; 181 (4): 894-904. DOI: https://doi.org/10.1016/j.cell.2020.03.045. 6. Lei C., Qian K., Li T., Zhang S., et al. Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig // Nat Commun. 2020; 11 (1): 2070. DOI: https://doi.org/10.1038/s41467-020-16048-4. 7. Donoghue M., Hsieh F., Baronas E., et al. A novel angiotensin-converting enzyme-relatedcarboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 // Circ Res. 2000; 87: E1-9. DOI: 10.1161/01.res.87.5.e1. 8. Santos R. A. S., Sampaio W. O., Alzamora A. C., Motta-Santos D., Alenina N., Bader M., et al. The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7) // Physiological Reviews. 2018; 98 (1): 505-553. DOI: 10.1152/physrev.00023.2016. 9. Голухова Е. З., Сливнева И. В., Рыбка М. М., Мамалыга М. Л., Алехин М. Н., Ключников И. В. и др. Легочная гипертензия как фактор оценки риска неблагоприятного исхода у пациентов с COVID-19 // Российский кардиологический журнал. 2020; 12 (25): 121-133. [Golukhova Ye. Z., Slivneva I. V., Rybka M. M., Mamalyga M. L., Alekhin M. N., Klyuchnikov I. V. i dr. Pulmonary hypertension as a risk factor for adverse outcomes in patients with COVID -19 // Rossiyskiy kardiologicheskiy zhurnal. 2020. T. 25, № 12. P. 121-133.] 10. Самсонова М. В., Михалева Л. М., Зайратьянц О. В., Варясин В. В., Быканова А. В., Мишнев О. Д. и др. Патология легких при COVID-19 в Москве // Архив патологии. 2020; 4 (82): 32-40. DOI: https://doi.org/10.17116/patol20208204132. [Samsonova M. V., Mikhaleva L. M., Zayrat'yants O. V., Varyasin V. V., Bykanova A. V., Mishnev O. D. i dr. Pulmonary pathology in COVID-19 in Moscow // Arkhiv patologii. 2020. T. 82, № 4. P. 32-40.] DOI: https://doi.org/10.17116/patol20208204132] 11. Wu Y. Compensation of ACE2 Function for Possible Clinical Management of 2019-nCoV-Induced Acute Lung Injury // Virologica Sinica. 2020; 35 (3): 256-258. DOI: 10.1007/s12250-020-00205-6. 12. Hamming I., Timens W., Bulthuis M., Lely A., Navis G., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis // The Journal of Pathology. 2004; 203 (2): 631-637. DOI: 10.1002/path.1570. 13. Alcocer-Díaz-Barreiro L., Cossio-Aranda J., Verdejo-Paris J., Odinde-Los-Ríos M., Galván-Oseguera H., Álvarez-López H. et al. COVID19 and the renin, angiotensin, aldosterone system. A complex relationship // Arch. Cardiol. Mex. 2020. Vol. 90, suppl. P. 19-25. DOI: https://doi. org/10.24875/ACM.M20000063. 14. Shi S., Qin M., Cai Y., Liu T., Shen B., Yang F. et al. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019 // European Heart Journal. 2020; 41 (22): 2070-2079. DOI: 10.1093/eurheartj/ehaa408. 15. Sala S., Peretto G., Gramegna M., Palmisano A., Villatore A., Vignale D. et al. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection // European Heart Journal. 2020; 41 (19): 1861-1862. DOI: 10.1093/eurheartj/ehaa286. 16. Ueki Y., Otsuka T., Windecker S., Räber L. ST-elevation myocardial infarction and pulmonary embolism in a patient with COVID-19 acute respiratory distress syndrome // European Heart Journal. 2020; 41 (22): 2134. DOI: 10.1093/eurheartj/ehaa399. 17. Dominguez-Erquicia P., Dobarro D., Raposeiras-Roubín S., Bastos Fernandez G., Iñiguez-Romo A. Multivessel coronary thrombosis in a patient with COVID-19 pneumonia // European Heart Journal. 2020; 41 (22): 2132. DOI: 10.1093/eurheartj/ehaa393. 18. Fernandez Gasso L., Maneiro Melon N. M., Sarnago Cebada F., Solis J., Garcia Tejada J. Multivessel spontaneous coronary artery dissection presenting in a patient with severe acute SARS-CoV-2 respiratory infection // European Heart Journal. 2020; 41 (32): 3100-3101. DOI: 10.1093/eurheartj/ehaa400. 19. Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study // The Lancet. 2020; 395 (10229): 1054-1062. DOI: 10.1016/S0140-6736(20)30566-3. 20. Dong E., Du H., Gardner L. An interactive web-based dashboard to track COVID-19 in real time // The Lancet Infectious Diseases. 2020; 20 (5): 533-534. DOI: 10.1016/S1473-3099(20)30120-1. 21. Clerkin K. J., Fried J. A., Raikhelkar J., Sayer G., Griffin J. M., Masoumi A. et al. COVID-19 and Cardiovascular Disease // Circulation. 2020; 141 (20): 1648-1655. DOI: 10.1161/CIRCULATIONAHA.120.04694. 22. Li X., Xu S., Yu M., Wang K., Tao Y., Zhou Y. et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan // Journal of Allergy and Clinical Immunology. 2020; 146 (1): 110-118. DOI: 10.1016/j.jaci.2020.04.006. 23. Cai Q., Chen F., Wang T., Luo F., Liu X., Wu Q. et al. Obesity and CO-VID-19 Severity in a Designated Hospital in Shenzhen, China // Diabetes Care. 2020; 43 (7): 1392-1398. DOI: 10.2337/dc20-0576. 24. Simonnet A., Chetboun M., Poissy J., Raverdy V., Noulette J., Duhamel A. et al. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation // Obesity. 2020; 28 (7): 1195-1199. DOI: 10.1002/oby.22831. 25. Shi Y., Yu X., Zhao H., Wang H., Zhao R., Sheng J. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan // Critical Care. 2020; 24 (1): 108. DOI: 10.1186/s13054-020-2833-7. 26. Wu C., Chen X., Cai Y., Xia J., Zhou X., Xu S. et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China // JAMA Internal Medicine. 2020; 180 (7): 934-43. DOI: 10.1001/jamainternmed.2020.0994. 27. European Society of Cardiology. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. Last updated on 10 June 2020. URL: https://www.escardio.org/Education/ COVID-19-and-Cardiology/ESC-COVID-19-Guidance (дата обращения: 18.02.2022). 28. Centers for Disease Control and Prevention. People at Increased Risk for Severe Illness. 2020.URL: https://www.cdc.gov/coronavirus/2019- ncov/need-extra-precautions/index.html (дата обращения: 18.02.2022). 29. Shibata S., Arima H., Asayama K., Hoshide S., Ichihara A., Ishimitsu T. et al. Hypertension and related diseases in the era of COVID-19: are port from the Japanese Society of Hypertension Task Force on COVID-19 // Hypertension Research. 2020; 43 (10): 1028-1046. DOI: 10.1038/s41440-020-0515-0.